Olink Holding AB Share Price

Equities

OLK

US6807101000

Office Equipment

Market Closed - Nasdaq 21:00:00 12/06/2024 BST 5-day change 1st Jan Change
24.87 USD +0.61% Intraday chart for Olink Holding AB +1.93% -1.11%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 204M 15.95B Sales 2025 * 270M 21.12B Capitalization 3.1B 243B
Net income 2024 * -1M -78.29M Net income 2025 * 61M 4.78B EV / Sales 2024 * 14.7 x
Net cash position 2024 * 115M 9.01B Net cash position 2025 * 133M 10.44B EV / Sales 2025 * 11 x
P/E ratio 2024 *
-1,658 x
P/E ratio 2025 *
50.8 x
Employees 707
Yield 2024 *
-
Yield 2025 *
-
Free-Float 33.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.61%
1 week+1.93%
Current month+3.84%
1 month+6.65%
3 months+4.50%
6 months-3.94%
Current year-1.11%
More quotes
1 week
24.35
Extreme 24.35
25.08
1 month
23.30
Extreme 23.3
25.08
Current year
21.68
Extreme 21.68
25.20
1 year
14.10
Extreme 14.1
26.01
3 years
8.39
Extreme 8.39
38.78
5 years
8.39
Extreme 8.39
42.20
10 years
8.39
Extreme 8.39
42.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 30/11/20
President 53 31/07/20
Director of Finance/CFO 39 29/02/20
Members of the board TitleAgeSince
Director/Board Member 66 31/12/17
Chairman 68 31/12/20
Chief Executive Officer 57 30/11/20
More insiders
Date Price Change Volume
12/06/24 24.87 +0.61% 360,500
11/06/24 24.72 -0.24% 174,380
10/06/24 24.78 +0.53% 204,918
07/06/24 24.65 +0.82% 450,824
06/06/24 24.45 +0.20% 185,928

Delayed Quote Nasdaq, June 12, 2024 at 09:00 pm

More quotes
Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
24.87 USD
Average target price
26 USD
Spread / Average Target
+4.54%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW